261 related articles for article (PubMed ID: 31515460)
1. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
Juthani R; Madajewski B; Yoo B; Zhang L; Chen PM; Chen F; Turker MZ; Ma K; Overholtzer M; Longo VA; Carlin S; Aragon-Sanabria V; Huse J; Gonen M; Zanzonico P; Rudin CM; Wiesner U; Bradbury MS; Brennan CW
Clin Cancer Res; 2020 Jan; 26(1):147-158. PubMed ID: 31515460
[TBL] [Abstract][Full Text] [Related]
2. Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.
Madajewski B; Chen F; Yoo B; Turker MZ; Ma K; Zhang L; Chen PM; Juthani R; Aragon-Sanabria V; Gonen M; Rudin CM; Wiesner U; Bradbury MS; Brennan C
Clin Cancer Res; 2020 Oct; 26(20):5424-5437. PubMed ID: 32723835
[TBL] [Abstract][Full Text] [Related]
3. Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma.
Aragon-Sanabria V; Aditya A; Zhang L; Chen F; Yoo B; Cao T; Madajewski B; Lee R; Turker MZ; Ma K; Monette S; Chen P; Wu J; Ruan S; Overholtzer M; Zanzonico P; Rudin CM; Brennan C; Wiesner U; Bradbury MS
Clin Cancer Res; 2022 Jul; 28(13):2938-2952. PubMed ID: 35499557
[TBL] [Abstract][Full Text] [Related]
4. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization.
Yoo B; Ma K; Zhang L; Burns A; Sequeira S; Mellinghoff I; Brennan C; Wiesner U; Bradbury MS
Bioorg Med Chem; 2015 Nov; 23(22):7119-30. PubMed ID: 26462054
[TBL] [Abstract][Full Text] [Related]
6. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
8. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T
Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer.
McKnight BN; Kim S; Boerner JL; Viola NT
Breast Cancer Res; 2020 Apr; 22(1):37. PubMed ID: 32295603
[TBL] [Abstract][Full Text] [Related]
11. Targeted melanoma radiotherapy using ultrasmall
Zhang X; Chen F; Turker MZ; Ma K; Zanzonico P; Gallazzi F; Shah MA; Prater AR; Wiesner U; Bradbury MS; McDevitt MR; Quinn TP
Biomaterials; 2020 May; 241():119858. PubMed ID: 32120314
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma model.
Benezra M; Hambardzumyan D; Penate-Medina O; Veach DR; Pillarsetty N; Smith-Jones P; Phillips E; Ozawa T; Zanzonico PB; Longo V; Holland EC; Larson SM; Bradbury MS
Neoplasia; 2012 Dec; 14(12):1132-43. PubMed ID: 23308046
[TBL] [Abstract][Full Text] [Related]
13. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.
Urbanska AM; Khanin R; Alidori S; Wong S; Mello BP; Almeida BA; Chen F; Ma K; Turker MZ; Korontsvit T; Scheinberg DA; Zanzonico PB; Wiesner U; Bradbury MS; Quinn TP; McDevitt MR
Cancer Biother Radiopharm; 2020 Aug; 35(6):459-473. PubMed ID: 32013538
[TBL] [Abstract][Full Text] [Related]
14. Overcoming Barriers Associated with Oral Delivery of Differently Sized Fluorescent Core-Shell Silica Nanoparticles.
Erstling JA; Bag N; Gardinier TC; Kohle FFE; DomNwachukwu N; Butler SD; Kao T; Ma K; Turker MZ; Feuer GB; Lee R; Naguib N; Tallman JF; Malarkey HF; Tsaur L; Moore WL; Chapman DV; Aubert T; Mehta S; Cerione RA; Weiss RS; Baird BA; Wiesner UB
Adv Mater; 2024 Jan; 36(1):e2305937. PubMed ID: 37689973
[TBL] [Abstract][Full Text] [Related]
15. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
[TBL] [Abstract][Full Text] [Related]
16. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
17. Monitoring Src status after dasatinib treatment in HER2+ breast cancer with
McKnight BN; Viola-Villegas NT
Breast Cancer Res; 2018 Oct; 20(1):130. PubMed ID: 30359299
[TBL] [Abstract][Full Text] [Related]
18. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier.
Miura Y; Takenaka T; Toh K; Wu S; Nishihara H; Kano MR; Ino Y; Nomoto T; Matsumoto Y; Koyama H; Cabral H; Nishiyama N; Kataoka K
ACS Nano; 2013 Oct; 7(10):8583-92. PubMed ID: 24028526
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
Porru M; Zappavigna S; Salzano G; Luce A; Stoppacciaro A; Balestrieri ML; Artuso S; Lusa S; De Rosa G; Leonetti C; Caraglia M
Oncotarget; 2014 Nov; 5(21):10446-59. PubMed ID: 25431953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
